about
Modulation of tumor necrosis factor by microbial pathogens.TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseGeneration and activation of multiple dimeric transcription factors within the NF-kappaB signaling systemExpanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) miceA role for Th17 cells in the regulation of tertiary lymphoid folliclesUse of the tumor necrosis factor-blockers for Crohn's diseaseBoth functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malariaIn vivo depletion of lymphotoxin-alpha expressing lymphocytes inhibits xenogeneic graft-versus-host-diseaseTranscriptomic Analysis of Persistent Infection with Foot-and-Mouth Disease Virus in Cattle Suggests Impairment of Apoptosis and Cell-Mediated Immunity in the NasopharynxLymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesisPlasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patientsDimerization of LT R by LT 1 2 is necessary and sufficient for signal transductionMechanistic Basis for Functional Promiscuity in the TNF and TNF Receptor Superfamilies: Structure of the LIGHT:DcR3 AssemblyStromal cell regulation of homeostatic and inflammatory lymphoid organogenesisFacilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 BlockadeRetinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunityMycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanismComparative persistence of the TNF antagonists in rheumatoid arthritis--a population-based cohort studyInflammatory bowel diseaseBiologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infectionEvolution and comparative analysis of the MHC Class III inflammatory regionDifferential RelA- and RelB-dependent gene transcription in LTbetaR-stimulated mouse embryonic fibroblastsLymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice.Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome.Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and futureExcess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia.Resurrection of a clinical antibody: template proteogenomic de novo proteomic sequencing and reverse engineering of an anti-lymphotoxin-α antibody.Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regressionLymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection.The LIGHT and DARC sides of herpesvirus entry mediatorRole of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.Generation of improved humanized mouse models for human infectious diseases.Sub-lethal irradiation of human colorectal tumor cells imparts enhanced and sustained susceptibility to multiple death receptor signaling pathways.Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models.Lymphotoxin, NF-ĸB, and cancer: the dark side of cytokines.Severe thymic atrophy in a mouse model of skin inflammation accounts for impaired TNFR1 signaling.Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo.LIGHT/TNFSR14 can regulate hepatic lipase expression by hepatocytes independent of T cells and Kupffer cells.Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)
P2860
Q21089629-56FF9392-C28D-4412-9364-02660CC49B59Q21093232-D23CB267-39CB-4B36-B595-85CEAD154F7BQ24641914-42AE756E-D1CF-4298-867F-A9522FD0299EQ24657377-AF68433C-D53A-4083-A4DE-A2B4D752DED0Q26851559-46564127-0E92-4376-B665-F550753EBBB6Q27030762-97FF5F91-4361-4BC7-9A5E-459CEF9DE14DQ27300897-7A07FEE0-D377-413E-8939-E81A52E64FA5Q27307168-7E6AFDAC-F946-41FE-8D44-40BCF163EF03Q27322442-EDBD6E3C-C96F-440C-B3B8-F30BC3284C3CQ27335708-2EC727E0-310B-4C9C-AE93-DAECF2A8C9CDQ27482532-84397587-5021-4A1E-933B-00881BDB5466Q27680632-266317C6-BAE7-407F-AE2D-E8F62FE7C40AQ27684921-7360FA5D-8416-4181-B0F7-9C6052174CF4Q27693895-EA29FDF9-EA1B-4874-AC14-90EE7216FBB6Q28119095-229F724D-9ADB-4DE1-84BF-67DB7B20B049Q28302355-BAE55F99-D4BC-4A30-96BF-C1C082F29125Q28469036-DD7CDCE7-54AD-4E24-901D-F485D6D268ECQ28542423-476BC955-2243-44FD-936E-26D7D5249EBBQ29615500-9A310287-C3C7-4CA8-BE09-C3A86E9C03E7Q30412650-2C9059AC-1461-428F-A666-BD0AFD9808F9Q31036509-D0E9EC1A-74EF-422D-AAB2-B61F96A67575Q33262512-2DA59BCB-8D9C-4F72-A093-FFB3CF3C92ADQ33393459-968D39C0-6F5C-44BE-ABF4-9FA2097BB934Q33399367-2AC90BC1-B789-4E65-9676-596EE6EFCD13Q33565851-1E452659-903C-4E55-91AF-EB32F706569AQ33601679-7088FEA4-A373-4FB6-B312-9F7F6A628349Q33740993-11D2E865-7A68-4F4C-887C-D4AA0F1D5195Q33804091-0D3FD072-AA9F-4069-BF39-EDBC6C79CF29Q33862487-43DE5ED6-2896-4C5D-823F-70185ED31E47Q33883606-BACA0B1B-8F96-44F9-AEBC-8F6FF354A44EQ34016123-D402619E-BF7E-441C-97CD-18423C0BBD7FQ34111943-D26EBBAB-0EB1-4274-824A-C69DC9C8953AQ34135605-2528A614-C833-41E3-BD00-872E06B8E883Q34184469-841EF58C-913A-4FB4-BA76-83FAC32CD59DQ34282683-4D9E70DA-7F76-4CBA-B671-15492E02C916Q34308847-2430A8C7-A825-468B-97BD-4EB89925437CQ34448191-5FE4717C-FFBF-4F88-94FB-48D991C8087FQ34489151-0C43FA3C-9C38-481A-924A-08701A634485Q34565128-C929A2B6-532E-4D6C-AEA9-C3512D99C80AQ34568533-BC87F026-8213-4E29-A266-BADE4BB4749C
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Network communications: lymphotoxins, LIGHT, and TNF.
@ast
Network communications: lymphotoxins, LIGHT, and TNF.
@en
type
label
Network communications: lymphotoxins, LIGHT, and TNF.
@ast
Network communications: lymphotoxins, LIGHT, and TNF.
@en
prefLabel
Network communications: lymphotoxins, LIGHT, and TNF.
@ast
Network communications: lymphotoxins, LIGHT, and TNF.
@en
P1476
Network communications: lymphotoxins, LIGHT, and TNF.
@en
P2093
Carl F Ware
P304
P356
10.1146/ANNUREV.IMMUNOL.23.021704.115719
P577
2005-01-01T00:00:00Z